Recall Register

Food, drugs, devices › Mindray DS USA, Inc. dba Mindray North America

Device recall: Hardware configuration of the BeneVision Central Monitoring System (CMS), marketed as BeneVision Distributed Monitoring

FDA enforcement event 97969 · Class II · initiated 18 Nov 2025 · status Ongoing

DeviceVoluntary: Firm initiated1 product recordMahwah, NJ

FDA enforcement event 97969 is a device recall by Mindray DS USA, Inc. dba Mindray North America of Mahwah, NJ, initiated 18 Nov 2025 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 85% of the 945 device enforcement events initiated in 2025 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Mindray DS USA, Inc. dba Mindray North America has 29 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Mindray DS USA, Inc. dba Mindray North America, Mahwah, NJ.

Reason for recall

"When the Worstation of the BeneVision DMS has a specific hardware configuration, the computer may experience audio playback failure or screen freezing."

Distribution

"Worldwide distribution - US Nationwide and the country of Canada."

Product records

Recall numberProductQuantityClassStatusReport date
Z-0920-2026Hardware configuration of the BeneVision Central Monitoring System (CMS), marketed as BeneVision Distributed Monitoring System (DMS). Model Number: 115-050935-00 and E115-050935-00. Software Version: Audio Driver version 6.0.9484.1 HP Pro Mini 400 G9 Desktop PC with Realtek HD Audio Driver Officially Released by HP…906 unitsClass IIOngoing24 Dec 2025

Context

85%of 2025 device events are Class II945 events that year
1product record in this eventfirm median: 1
29events on this register for the firm

Other enforcement events for Mindray DS USA, Inc. dba Mindray North America

InitiatedProduct (first record)TypeClassRecords
20 Oct 2025Sevoflurane (SEVO) V90 Electronic Vaporizer with the A9 Anesthesia System. Labeled as the following: 1. Sev E_Vap. (SafeDeviceClass II2
15 Aug 2025BeneVision N1 Patient Monitor (N1). Part Numbers: 6660E-PA00017, 6660E-PA00014, 6660E-PA00012, 6660E-PA00011, 6660E-PA00DeviceClass II1
22 Jul 2024Sevoflurane E_Vap.(Quik-Fil):used with the A9 Anesthesia System-Used to provide the vapor of an anesthetic agent with coDeviceClass II4
27 May 20213AA battery cradle (Part Number 045-001699-01) used with BeneVision TD60 Telepack (Model Number 115-047566-00 /115-06004DeviceClass III1
22 Feb 2021Mindray BeneVision Distributed Monitoring System( DMS) 1. p/n 115-051209-00 2. p/n 115-034414-00 and 115-034413-00 when DeviceClass II1
13 Jan 2020DP-30 Digital Ultrasonic Diagnostic Imaging System, Part No. 1155E-PA00004 - Product Usage: The Digital Ultrasonic DiagnDeviceClass II1
9 Dec 2019BA-800M Chemistry Analyzer Part Numbers BA81E-PA00002 and BA81E-PA00003, Containing Gas spring YQ-8/18-90-272-180N (MateDeviceClass II2
1 Oct 2019Accutorr 3 Vital Signs Monitor with NIBP valve assembly board, p/n 115-017679-00, containing software version 8.1.5 - PrDeviceClass II4
30 Aug 2018Mindray BeneVision Distributed Monitoring System (DMS), Part No. 115-034413-00DeviceClass II1
24 Jan 2018Hematology Diluent M-30D used with BC-3200 and BC-3600 Hematology Analyzer; Part Numbers: (1) 105-005405-00 (2 x 5.5L coDeviceClass II2

All 29 events for Mindray DS USA, Inc. dba Mindray North America

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "When the Worstation of the BeneVision DMS has a specific hardware configuration, the computer may experience audio playback failure or screen freezing."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide distribution - US Nationwide and the country of Canada."

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.